查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829344

2025年全球鼻腔給藥裝置市場報告

Intranasal Drug Delivery Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，鼻腔給藥裝置市場規模強勁成長，從2024年的602.7億美元增加至2025年的650.9億美元，複合年成長率為8.0%。預測期內的成長可歸因於慢性呼吸系統疾病的增加、患者偏好和依從性、自我給藥的便利性、兒科應用、過敏性鼻炎治療市場的擴張以及適應症的廣泛性。

預計未來幾年，鼻腔給藥裝置市場規模將強勁成長，到2029年將達到910.5億美元，複合年成長率為8.8%。預測期內的成長可歸因於多種因素，例如老年人口的成長、全球呼吸系統疾病的日益嚴重、神經系統疾病應用的不斷拓展、個性化醫療的趨勢、預防醫學的投入以及新興國家的市場滲透。預測期內的主要趨勢包括製劑技術的進步、對兒科和老年病應用的關注、自我給藥裝置和鼻腔粉吸入器的興起，以及生技藥品和多肽的加入。

鼻腔給藥裝置是用於將藥物輸送至鼻腔的醫療設備。這些裝置專門設計用於將藥物直接輸送至血管豐富的鼻粘膜，鼻粘膜具有較大的表面積，可促進藥物快速吸收進入血液。鼻腔給藥裝置可將各種形式的藥物和治療物質（包括噴霧劑、粉末和液體）直接輸送至鼻腔。

鼻腔給藥裝置領域的主要產品包括粉末給藥裝置、液體給藥裝置、加壓定量吸入器及其他相關裝置。粉末給藥裝置是醫療器材或藥物裝置的一種，用於給藥單位劑量或多劑量藥物，適用於治療各種疾病，包括慢性阻塞性肺病(COPD)、鼻炎、囊腫纖維化、鼻塞和氣喘。這些裝置的最終使用者包括醫院、診所、居家照護和其他醫療保健機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供鼻腔給藥裝置市場統計數據，包括全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的鼻腔給藥裝置細分市場、市場趨勢和商機，以及您在鼻腔給藥裝置行業取得成功所需的數據。本鼻腔給藥裝置市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年8.8%的預測成長率，較我們先前對該市場的預測略有下降0.1%。下降主要源自於美國與其他國家之間關稅的影響。美國經濟和貿易的負面影響，這種影響也可能影響更廣泛的領域。

慢性病盛行率的上升預計將在未來幾年推動鼻腔給藥裝置市場的成長。慢性病是指持續一年以上，需要持續醫療照護、限制日常活動或兩者兼具的疾病。鼻腔給藥裝置是一種非侵入性且有效的給藥方式，可用於治療慢性病。此類裝置可將藥物直接輸送至目標部位，方便易用且吸收迅速。例如，英國政府機構國家醫療服務體系（NHS）於2024年6月報告稱，2023年，英格蘭將有超過50萬例（549,000例）新病例被確診為有患2型糖尿病的風險。這將使在全科醫生登記的非糖尿病高血糖或糖尿病前期患者總數達到3,615,330人，較2022年的3,065,825人大幅增加近20%。因此，慢性病盛行率的不斷上升正在刺激鼻腔給藥裝置市場的擴張。

非侵入性給藥方法日益成長的需求也有望促進鼻腔給藥裝置市場的擴張。非侵入性給藥涉及將藥物輸送到體內，而無需穿透或切開皮膚或黏膜。鼻腔給藥裝置促進了這種方法，在使鼻腔給藥變得簡單有效方面發揮關鍵作用。這些裝置利用鼻腔廣泛的血管網路並確保快速吸收，從而提高藥物生物生物有效性，提高患者依從性，並消除侵入性操作的需要。例如，美國美學協會於 2023 年 8 月發布的數據顯示，美國非手術程序顯著增加，預計到 2022 年，身體塑形、皮膚護理、毒素和微針療法將分別增加 31%、26%、24% 和 23%。因此，對非侵入性給藥方法日益成長的需求是推動鼻腔給藥裝置市場擴張的主要因素。

鼻腔給藥技術市場領先的製藥公司正在積極開發新產品和改進產品，以提供創新的給藥方法並保持其市場地位。例如，2023年1月，美國藥物輸送和製藥公司AptarGroup, Inc.推出了APF Futurity，這是首款可回收、無金屬、多劑量鼻噴霧，用於輸送鼻腔生理食鹽水和類似的非處方(OTC)製劑。該產品由聚烯材料製成，不含金屬成分和干擾回收的物質，減少了回收流程中的分離需求，並支援更高等級的回收材料。值得注意的是，APF Futurity是一款高度可回收的滴鼻劑泵，並已獲得cyclos-HTP頒發的歐洲回收流程AA級認證。

2022年3月，諾華集團旗下瑞士生物製藥公司山德士股份公司（Sandoz AG）收購了Coalesce Product Development Limited，收購金額未揭露。此策略措施旨在增強山德士在吸入式給藥領域的能力，豐富其產品組合，並加速鼻腔給藥裝置的開發和商業化進程。 Coalesce Product Development Limited總部位於英國，專注於藥物輸送裝置的開發，包括鼻腔給藥。

鼻腔給藥裝置市場報告的主要企業包括強生公司、默克公司、諾華公司、阿斯特捷利康公司、葛蘭素史克公司、3M 公司、貝克頓、迪金森公司、梯瓦製藥工業有限公司、阿普塔集團公司、West Pharmaceutical Services 公司、泰利福公司、Recipharm AB、Nemera Development SA、Consort Ltd Services 公司、泰利福公司、Recipharm AB、Nemera Development SA、Consort Ltd Pvans、Virtical Pharmaceuticals、Optinoset Inc.、Flamel Technologies、 Aegis Therapeutics LLC、Sonoma Pharmaceuticals、Pendopharm Inc.、Kurbe Technology Inc.、Impel Neuropharma、Imexium Medical Products、BF Usher & Company Inc.、ENT Technologies Pty. Ltd.、Neurelis Inc.、Generex Biotechnology Corporation

2024 年，北美是鼻腔給藥裝置市場最大的地區。鼻腔給藥裝置市場報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

鼻腔給藥裝置市場報告涉及的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利和西班牙。

鼻腔給藥裝置市場包括鼻噴霧、鼻粉劑裝置、鼻用抗精神病藥物、鼻用腎上腺素裝置、滴鼻劑和鼻吸入器的銷售。該市場的價值為“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球鼻腔給藥裝置：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球鼻腔給藥裝置市場：成長率分析
  • 全球鼻腔給藥裝置市場表現：規模與成長，2019-2024
  • 全球鼻腔給藥裝置市場預測：規模與成長，2024-2029年，2034年
  • 全球鼻腔給藥裝置：總目標市場（TAM）

第6章 市場細分

  • 全球鼻腔給藥裝置市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 送粉裝置
  • 液體輸送裝置
  • 加壓定量吸入器
  • 其他產品
  • 全球鼻腔給藥裝置市場（依劑量、實際及預測），2019-2024 年、2024-2029 年、2034 年
  • 單位劑量
  • 多劑量
  • 全球鼻腔給藥裝置市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 慢性阻塞性肺病（COPD）
  • 鼻炎
  • 囊腫纖維化
  • 鼻塞
  • 氣喘
  • 其他用途
  • 全球鼻腔給藥裝置市場：依最終用戶、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 居家護理
  • 其他最終用戶
  • 全球鼻腔給藥裝置市場：粉末輸送裝置（類型）細分、性能及預測，2019-2024 年、2024-2029 年、2034 年
  • 單劑量粉末裝置
  • 多劑量粉末裝置
  • 全球鼻腔給藥裝置市場：液體輸送裝置（類型）細分、效能及預測，2019-2024 年、2024-2029 年、2034 年
  • 單劑量液體裝置
  • 多劑量液體裝置
  • 全球鼻腔給藥裝置市場：按壓力定量吸入器 (pMDI) 細分，類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 呼吸激活PMDI
  • 常規pMDI
  • 全球鼻腔給藥裝置市場：依產品類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 凝膠輸送裝置
  • 噴霧器
  • 鼻噴劑

第7章 區域和國家分析

  • 全球鼻腔給藥裝置市場：區域分析、預測與趨勢（2019-2024 年、2024-2029 年及 2034 年）
  • 全球鼻腔給藥裝置市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 鼻腔給藥裝置市場：競爭格局
  • 鼻腔給藥裝置市場：公司簡介
    • Johnson and Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • 3M Company
  • Becton, Dickinson and Company
  • Teva Pharmaceutical Industries Ltd.
  • AptarGroup Inc.
  • West Pharmaceutical Services Inc.
  • Teleflex Incorporated
  • Recipharm AB
  • Nemera Development SA
  • Consort Medical plc.
  • Vectura Group plc
  • Douglas Pharmaceuticals Ltd.
  • Avanir Pharmaceuticals
  • OptiNoset Inc.
  • Flamel Technologies
  • Aegis Therapeutics LLC

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年鼻腔給藥裝置市場：提供新機會的國家
  • 2029年鼻腔給藥裝置市場：細分市場帶來新機會
  • 2029年鼻腔給藥裝置市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r28357u

Intranasal drug delivery devices are medical instruments designed to administer medications into the nasal cavity. These devices are specifically created to deliver medications directly to the highly vascularized nasal mucosa, which boasts a substantial surface area, facilitating rapid absorption of the drug into the bloodstream. Intranasal drug delivery devices are capable of delivering drugs or therapeutic substances in various forms, including sprays, powders, or liquid solutions, directly into the nasal cavity.

The primary products within the realm of intranasal drug delivery devices include powder delivery devices, liquid delivery devices, pressurized metered-dose inhalers, and other related devices. Powder delivery devices, a subtype of medical or pharmaceutical devices, are designed for administering medications in unit-dose or multi-dose forms and find applications in various medical conditions such as chronic obstructive pulmonary disease (COPD), rhinitis, cystic fibrosis, nasal congestion, asthma, among others. The end users of these devices include hospitals, clinics, homecare, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The intranasal drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides intranasal drug delivery devices market statistics, including intranasal drug delivery devices industry global market size, regional shares, competitors with a intranasal drug delivery devices market share, detailed intranasal drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the intranasal drug delivery devices industry. This intranasal drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intranasal drug delivery devices market size has grown strongly in recent years. It will grow from $60.27 billion in 2024 to $65.09 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to rise in chronic respiratory diseases, patient preference and compliance, convenience in self-administration, pediatric applications, market expansion in allergic rhinitis treatment, wider range of indications.

The intranasal drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $91.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing geriatric population, rising global respiratory issues, expanding applications in neurological disorders, personalized medicine trends, preventive healthcare initiatives, market penetration in emerging economies. Major trends in the forecast period include advances in formulation technologies, focus on pediatric and geriatric applications, rise in self-administration devices, nasal powder inhalers, incorporation of biologics and peptides.

The forecast of 8.8% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for precision atomizing nozzles and biocompatible nasal adapters, sourced from key regions such as Germany and Switzerland, which could lead to reduced effectiveness of nasal vaccines and increased costs for alternative drug delivery methods.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of chronic diseases is anticipated to drive the growth of the intranasal drug delivery devices market in the coming years. Chronic diseases are defined as conditions lasting one year or more that require ongoing medical care, restrict daily activities, or both. Intranasal drug delivery devices are employed to manage chronic diseases by providing a non-invasive and effective means of administering medications. These devices enable medications to be delivered directly to the targeted area, offering convenience, ease of use, and promoting rapid absorption. For example, in June 2024, the National Health Service (NHS), a UK-based government agency, reported that in 2023, over half a million (549,000) additional individuals in England were identified as being at risk of developing type 2 diabetes. This brought the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a general practitioner to 3,615,330, marking a significant increase from 3,065,825 in 2022 and representing nearly a 20% rise. Therefore, the growing prevalence of chronic diseases is fueling the expansion of the intranasal drug delivery devices market.

The growing demand for non-invasive drug delivery methods is also expected to contribute to the expansion of the intranasal drug delivery device market. Non-invasive drug delivery involves administering pharmaceutical substances into the body without the need for skin or mucous membrane penetration or incision. Intranasal drug delivery devices play a crucial role in facilitating this approach, making it easy and effective to administer drugs through the nose. Leveraging the nose's extensive blood vessel network and ensuring fast absorption, these devices enhance drug bioavailability, improve patient adherence, and eliminate the need for invasive procedures. For example, data from The Aesthetic Society in August 2023 highlighted a significant increase in nonsurgical procedures in the U.S., with body contouring, skin treatment, toxins, and micro-needling showing growth rates of 31%, 26%, 24%, and 23%, respectively, in 2022. As a result, the growing demand for non-invasive drug delivery methods is a key driver for the expansion of the intranasal drug delivery device market.

Major pharmaceutical companies in the nasal drug delivery technology market are actively engaged in developing new and improved products to offer innovative drug administration methods and maintain their market position. For instance, in January 2023, AptarGroup, Inc., a US-based drug delivery and pharmaceutical company, introduced APF Futurity, the first recyclable, metal-free, multidose nasal spray for delivering nasal saline and similar over-the-counter (OTC) formulations. This product, made from polyolefin materials and devoid of metal components or recycling disruptors, reduces the need for separation in recycling streams and supports a higher grade of recycled materials. Notably, APF Futurity is a highly recyclable nasal spray pump that has obtained Class AA certification from cyclos-HTP for recycling streams in Europe.

In March 2022, Sandoz AG, a Switzerland-based biopharmaceutical company under the Novartis Group, acquired Coalesce Product Development Limited for an undisclosed amount. This strategic move aims to enhance Sandoz's capabilities in inhalation drug delivery, add a commercial-stage product to its portfolio, and expedite the development and commercialization of intranasal drug delivery devices. Coalesce Product Development Limited, based in the UK, specializes in drug delivery device development, including nasal drug delivery.

Major companies operating in the intranasal drug delivery devices market report are Johnson and Johnson Inc., Merck and Co.Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Teleflex Incorporated, Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group PLC, Douglas Pharmaceuticals Ltd., Avanir Pharmaceuticals, OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, Sonoma Pharmaceuticals, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, B.F. Ascher and Company Inc., ENT Technologies Pty. Ltd., Neurelis Inc., Generex Biotechnology Corporation

North America was the largest region in the intranasal drug delivery devices market in 2024. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intranasal drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The intranasal drug delivery devices market consists of sales of nasal sprays, nasal powder devices, nasal antipsychotic medications, nasal epinephrine devices, nasal drops, and nasal inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intranasal Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intranasal drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intranasal drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intranasal drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Powder Delivery Device; Liquid Delivery Device; Pressurized Metered-Dose Inhalers; Other Products
  • 2) By Dosage: Unit-Dose; Multi-Dose
  • 3) By Application: Chronic Obstructive Pulmonary Disease (COPD); Rhinitis; Cystic Fibrosis; Nasal Congestion; Asthma; Other Applications
  • 4) By End User: Hospitals; Clinics; Homecare; Other End Users
  • Subsegments:
  • 1) By Powder Delivery Device: Single-Dose Powder Device; Multi-Dose Powder Device
  • 2) By Liquid Delivery Device: Single-Dose Liquid Device; Multi-Dose Liquid Device
  • 3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs; Conventional pMDIs
  • 4) By Other Products: Gel Delivery Device; Nebulizers; Nasal Sprays
  • Companies Mentioned: Johnson and Johnson Inc.; Merck and Co.Inc.; Novartis AG; AstraZeneca plc.; GlaxoSmithKline Plc; 3M Company; Becton, Dickinson and Company; Teva Pharmaceutical Industries Ltd.; AptarGroup Inc.; West Pharmaceutical Services Inc.; Teleflex Incorporated; Recipharm AB; Nemera Development S.A.; Consort Medical plc.; Vectura Group plc; Douglas Pharmaceuticals Ltd.; Avanir Pharmaceuticals; OptiNoset Inc.; Flamel Technologies; Aegis Therapeutics LLC; Sonoma Pharmaceuticals; PendoPharm Inc.; Kurve Technology Inc.; Impel NeuroPharma; Impexium Medical Products; B.F. Ascher and Company Inc.; ENT Technologies Pty. Ltd.; Neurelis Inc.; Generex Biotechnology Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intranasal Drug Delivery Devices Market Characteristics

3. Intranasal Drug Delivery Devices Market Trends And Strategies

4. Intranasal Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Intranasal Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Intranasal Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Intranasal Drug Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Intranasal Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Intranasal Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Intranasal Drug Delivery Devices Total Addressable Market (TAM)

6. Intranasal Drug Delivery Devices Market Segmentation

  • 6.1. Global Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Powder Delivery Device
  • Liquid Delivery Device
  • Pressurized Metered-Dose Inhalers
  • Other Products
  • 6.2. Global Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Unit-Dose
  • Multi-Dose
  • 6.3. Global Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Rhinitis
  • Cystic Fibrosis
  • Nasal Congestion
  • Asthma
  • Other Applications
  • 6.4. Global Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Homecare
  • Other End Users
  • 6.5. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Powder Delivery Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose Powder Device
  • Multi-Dose Powder Device
  • 6.6. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Liquid Delivery Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose Liquid Device
  • Multi-Dose Liquid Device
  • 6.7. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Pressurized Metered-Dose Inhalers (pMDIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Breath-Actuated PMDIs
  • Conventional pMDIs
  • 6.8. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gel Delivery Device
  • Nebulizers
  • Nasal Sprays

7. Intranasal Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Intranasal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Intranasal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intranasal Drug Delivery Devices Market

  • 8.1. Asia-Pacific Intranasal Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intranasal Drug Delivery Devices Market

  • 9.1. China Intranasal Drug Delivery Devices Market Overview
  • 9.2. China Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intranasal Drug Delivery Devices Market

  • 10.1. India Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intranasal Drug Delivery Devices Market

  • 11.1. Japan Intranasal Drug Delivery Devices Market Overview
  • 11.2. Japan Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intranasal Drug Delivery Devices Market

  • 12.1. Australia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intranasal Drug Delivery Devices Market

  • 13.1. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intranasal Drug Delivery Devices Market

  • 14.1. South Korea Intranasal Drug Delivery Devices Market Overview
  • 14.2. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intranasal Drug Delivery Devices Market

  • 15.1. Western Europe Intranasal Drug Delivery Devices Market Overview
  • 15.2. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intranasal Drug Delivery Devices Market

  • 16.1. UK Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intranasal Drug Delivery Devices Market

  • 17.1. Germany Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intranasal Drug Delivery Devices Market

  • 18.1. France Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intranasal Drug Delivery Devices Market

  • 19.1. Italy Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intranasal Drug Delivery Devices Market

  • 20.1. Spain Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intranasal Drug Delivery Devices Market

  • 21.1. Eastern Europe Intranasal Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intranasal Drug Delivery Devices Market

  • 22.1. Russia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intranasal Drug Delivery Devices Market

  • 23.1. North America Intranasal Drug Delivery Devices Market Overview
  • 23.2. North America Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intranasal Drug Delivery Devices Market

  • 24.1. USA Intranasal Drug Delivery Devices Market Overview
  • 24.2. USA Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intranasal Drug Delivery Devices Market

  • 25.1. Canada Intranasal Drug Delivery Devices Market Overview
  • 25.2. Canada Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intranasal Drug Delivery Devices Market

  • 26.1. South America Intranasal Drug Delivery Devices Market Overview
  • 26.2. South America Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intranasal Drug Delivery Devices Market

  • 27.1. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intranasal Drug Delivery Devices Market

  • 28.1. Middle East Intranasal Drug Delivery Devices Market Overview
  • 28.2. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intranasal Drug Delivery Devices Market

  • 29.1. Africa Intranasal Drug Delivery Devices Market Overview
  • 29.2. Africa Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intranasal Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Intranasal Drug Delivery Devices Market Competitive Landscape
  • 30.2. Intranasal Drug Delivery Devices Market Company Profiles
    • 30.2.1. Johnson and Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis

31. Intranasal Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. 3M Company
  • 31.2. Becton, Dickinson and Company
  • 31.3. Teva Pharmaceutical Industries Ltd.
  • 31.4. AptarGroup Inc.
  • 31.5. West Pharmaceutical Services Inc.
  • 31.6. Teleflex Incorporated
  • 31.7. Recipharm AB
  • 31.8. Nemera Development S.A.
  • 31.9. Consort Medical plc.
  • 31.10. Vectura Group plc
  • 31.11. Douglas Pharmaceuticals Ltd.
  • 31.12. Avanir Pharmaceuticals
  • 31.13. OptiNoset Inc.
  • 31.14. Flamel Technologies
  • 31.15. Aegis Therapeutics LLC

32. Global Intranasal Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intranasal Drug Delivery Devices Market

34. Recent Developments In The Intranasal Drug Delivery Devices Market

35. Intranasal Drug Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Intranasal Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Intranasal Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Intranasal Drug Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer